Oracle Life Sciences Argus Safety 8.2.3 Login improper authentication

Summaryinfo

A vulnerability classified as critical has been found in Oracle Life Sciences Argus Safety 8.2.3. This impacts an unknown function of the component Login. Performing a manipulation results in improper authentication. This vulnerability is identified as CVE-2025-21570. The attack can be initiated remotely. There is not any exploit available. It is recommended to upgrade the affected component.

Detailsinfo

A vulnerability classified as critical has been found in Oracle Life Sciences Argus Safety 8.2.3. This affects some unknown processing of the component Login. The manipulation with an unknown input leads to a improper authentication vulnerability. CWE is classifying the issue as CWE-287. When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:

Vulnerability in the Oracle Life Sciences Argus Safety product of Oracle Health Sciences Applications (component: Login). The supported version that is affected is 8.2.3. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Argus Safety. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Life Sciences Argus Safety, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Argus Safety accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Argus Safety accessible data. CVSS 3.1 Base Score 6.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N).

It is possible to read the advisory at oracle.com. This vulnerability is uniquely identified as CVE-2025-21570 since 12/25/2024. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 01/21/2025).

Upgrading eliminates this vulnerability.

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Productinfo

Vendor

• Oracle

Name

• Life Sciences Argus Safety

Version

• 8.2.3

License

• commercial

Website

• Vendor: https://www.oracle.com

CPE 2.3info

• 🔍
• 🔍

CPE 2.2info

• 🔍
• 🔍

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Discussion